|
|
|
Insider
Information: |
Barer Sol J |
Relationship: |
Director |
City: |
Warren |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
10 |
|
Direct
Shares |
5,895,217 |
|
Indirect Shares
|
2,793,946 |
|
|
Direct
Value |
$81,933,052 |
|
|
Indirect Value
|
$6,974,534 |
|
|
Total
Shares |
8,689,163 |
|
|
Total
Value |
$88,907,586 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Celgene Corp |
CELG |
Director |
2011-01-13 |
692,192 |
2011-01-13 |
61,281 |
Premium* |
|
Amicus Therapeutics Inc |
FOLD |
Director |
2013-03-15 |
45,000 |
2009-11-04 |
0 |
Premium* |
|
Aegerion Pharmaceuticals, Inc. |
AEGR |
Director |
2016-11-29 |
0 |
2011-05-05 |
0 |
Premium* |
|
Inspiremd, Inc |
NSPR |
Director |
2016-03-21 |
1,141,690 |
2016-03-21 |
170,000 |
Premium* |
|
Aevi Genomic Medicine Inc |
GNMX |
Director |
2019-12-05 |
0 |
2019-12-05 |
0 |
Premium* |
|
Cervomed Ord Shs |
CRVO |
Chairman of the Board,... |
2014-06-06 |
1,011,072 |
|
0 |
Premium* |
|
Contrafect Corp |
CFRX |
Director |
2017-07-25 |
815,933 |
|
0 |
Premium* |
|
PDS Biotechnology Corp |
PDSB |
Director |
2015-10-06 |
0 |
2019-03-15 |
678,075 |
Premium* |
|
Teva Pharmaceutical Industries L... |
TEVA |
Director |
2023-08-04 |
371,516 |
2018-09-03 |
0 |
Premium* |
|
Neximmune, Inc. |
NEXI |
Director |
2022-11-17 |
1,817,814 |
2022-11-17 |
1,884,590 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
122 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CELG |
Celgene Corp |
Chief Executive Officer |
|
2007-12-10 |
4 |
OE |
$12.59 |
$99,974 |
D/D |
7,892 |
738,760 |
0 |
- |
|
CELG |
Celgene Corp |
Chief Executive Officer |
|
2008-01-02 |
4 |
OE |
$0.71 |
$85,438 |
D/D |
119,728 |
858,488 |
0 |
- |
|
CELG |
Celgene Corp |
Chief Executive Officer |
|
2008-05-12 |
4 |
OE |
$1.38 |
$5,953,208 |
D/D |
903,128 |
1,205,768 |
0 |
- |
|
CELG |
Celgene Corp |
Chief Executive Officer |
|
2008-05-12 |
4 |
S |
$61.76 |
$55,784,855 |
D/D |
(903,128) |
858,488 |
0 |
- |
|
CELG |
Celgene Corp |
Chief Executive Officer |
|
2008-07-30 |
4 |
AS |
$73.73 |
$5,898,128 |
D/D |
(80,000) |
778,448 |
0 |
- |
|
CELG |
Celgene Corp |
Chief Executive Officer |
|
2008-09-29 |
4 |
OE |
$12.59 |
$199,947 |
D/D |
15,784 |
794,272 |
0 |
- |
|
CELG |
Celgene Corp |
Chief Executive Officer |
|
2008-10-30 |
4 |
S |
$63.38 |
$15,869,191 |
D/D |
(250,388) |
543,884 |
0 |
- |
|
CELG |
Celgene Corp |
Chief Executive Officer |
|
2009-09-14 |
4 |
OE |
$6.45 |
$3,868,800 |
D/D |
600,000 |
1,143,884 |
0 |
- |
|
CELG |
Celgene Corp |
Chief Executive Officer |
|
2009-09-14 |
4 |
S |
$52.12 |
$31,274,460 |
D/D |
(600,000) |
543,884 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Director |
|
2009-11-04 |
4 |
B |
$4.13 |
$82,600 |
D/D |
20,000 |
20,000 |
2.39 |
- |
|
CELG |
Celgene Corp |
Executive Chairman |
|
2010-09-08 |
4 |
OE |
$42.39 |
$7,164,588 |
D/D |
169,016 |
749,260 |
0 |
- |
|
CELG |
Celgene Corp |
Executive Chairman |
|
2010-09-08 |
4 |
D |
$53.98 |
$8,072,493 |
D/D |
(149,546) |
599,714 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2010-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
59,144 |
658,858 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2011-01-13 |
4 |
AS |
$57.38 |
$4,315,134 |
D/D |
(75,200) |
692,192 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2011-01-13 |
4 |
OE |
$26.35 |
$2,859,871 |
D/D |
108,534 |
767,392 |
0 |
- |
|
AEGR |
Aegerion Pharmaceuticals,... |
Director |
|
2011-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
29,890 |
29,890 |
0 |
- |
|
NSPR |
Inspiremd, Inc |
Director |
|
2011-09-28 |
4 |
OE |
$1.50 |
$1,500,000 |
D/D |
1,000,000 |
1,000,000 |
0 |
- |
|
NSPR |
Inspiremd, Inc |
Director |
|
2011-11-16 |
4 |
A |
$0.00 |
$0 |
D/D |
2,900,000 |
3,900,000 |
0 |
- |
|
NSPR |
Inspiremd, Inc |
Director |
|
2012-11-16 |
4 |
B |
$1.27 |
$45,103 |
D/D |
35,559 |
3,935,559 |
2.39 |
- |
|
NSPR |
Inspiremd, Inc |
Director |
|
2012-11-19 |
4 |
B |
$1.38 |
$19,992 |
D/D |
14,441 |
3,950,000 |
2.39 |
- |
|
NSPR |
Inspiremd, Inc |
Director |
|
2012-11-20 |
4 |
B |
$1.29 |
$19,449 |
D/D |
15,020 |
3,965,020 |
2.39 |
- |
|
NSPR |
Inspiremd, Inc |
Director |
|
2012-11-21 |
4 |
B |
$1.33 |
$46,516 |
D/D |
34,980 |
4,000,000 |
2.39 |
- |
|
GNMX |
Aevi Genomic Medicine Inc |
Director |
|
2013-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
7,000 |
7,000 |
0 |
- |
|
FOLD |
Amicus Therapeutics Inc |
Director |
|
2013-03-15 |
4 |
B |
$3.40 |
$85,000 |
D/D |
25,000 |
45,000 |
2.39 |
- |
|
NSPR |
Inspiremd, Inc |
Director |
|
2013-04-16 |
4 |
B |
$2.00 |
$1,500,000 |
D/D |
750,000 |
1,750,000 |
2.39 |
- |
|
122 Records found
|
|
Page 2 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|